Merger and Acquisition Partnering Terms & Agreements Reviewed in New Topical Report by CurrentPartnering
17 Jan 2013 • by Natalie Aster
Comprehensive understanding and unprecedented access to the merger and acquisition agreements entered into by the world leading biopharma companies are provided in new “Merger and Acquisition Terms and Agreements” report by CurrentPartnering. The study provides a detailed understanding and analysis of how and why companies enter merger and acquisition deals.
Merger and Acquisition Terms and Agreements
Published: December, 2012
Price: US$ 2,995.00
Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.
This report contains a comprehensive listing of all merger and acquisition deals announced since 2009 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual merger and acquisition contract documents as submitted to the Securities Exchange Commission by companies and their partners.
More information can be found in the report “Merger and Acquisition Terms and Agreements” by CurrentPartnering.
To order the report or ask for sample pages contact [email protected]